254 related articles for article (PubMed ID: 6541198)
1. Comparative study of two regimens of combined chemotherapy of one year duration in multibacillary leprosy. Results after four and five years' follow-up.
Pattyn SR; André PS; Ferracci C; Baquillon G
Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):297-303. PubMed ID: 6541198
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and bacteriological assessment 8 years after triple-drug therapy for multibacillary leprosy in Senegal].
Dousset-Faure I; Millan J; Decazes JM; Languillon J
Acta Leprol; 1986; 4(4):465-72. PubMed ID: 3296618
[TBL] [Abstract][Full Text] [Related]
3. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
4. Treatment of paucibacillary leprosy with a regimen containing rifampicin, dapsone and prothionamide.
Katoch K; Natarajan M; Bhatia AS; Yadav VS
Indian J Lepr; 1992; 64(3):303-12. PubMed ID: 1431319
[TBL] [Abstract][Full Text] [Related]
5. [5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980].
Cartel JC; Gallais JJ; Naudillon Y; Millan J; Grosset JH
Acta Leprol; 1986; 4(4):415-25. PubMed ID: 3296612
[TBL] [Abstract][Full Text] [Related]
6. Combined regimens of one year duration in the treatment of multibacillary leprosy--II. Combined regimens with rifampicin administered during 6 months.
Pattyn SR; Groenen G; Janssens L; Deverchin J; Ghys P
Lepr Rev; 1989 Jun; 60(2):118-23. PubMed ID: 2671560
[TBL] [Abstract][Full Text] [Related]
7. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy].
Pattyn SR; Husser JA; Saint-André P
Acta Leprol; 1986; 4(4):445-6. PubMed ID: 3296614
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
10. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
11. [New drugs in the treatment of leprosy].
De Las Aguas JT
Med Cutan Ibero Lat Am; 1976; 4(5):365-70. PubMed ID: 1035391
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients.
Katoch K; Ramu G; Ramanathan U; Desikan KV
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):1-8. PubMed ID: 3559333
[TBL] [Abstract][Full Text] [Related]
13. [Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences].
Millan J; Roux G; Loko S; Naudin JC; Boucher P; Bodian M; Camara M; Moreira-Diop T; Grosset J
Acta Leprol; 1986; 4(4):427-44. PubMed ID: 3296613
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic trials with different regimens containing rifampicin in paucibacillary type of leprosy cases--a preliminary report.
Katoch K; Ramu G; Ramanathan U
Indian J Lepr; 1985; 57(3):499-506. PubMed ID: 3831087
[TBL] [Abstract][Full Text] [Related]
15. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
Colin M; de Montaigne E
Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283
[TBL] [Abstract][Full Text] [Related]
19. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two multidrug regimens in multibacillary leprosy.
Jadhav VH; Patki AH; Mehta JM
Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
